Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2012 August;64(4) > Minerva Ginecologica 2012 August;64(4):337-44

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

REVIEWS   

Minerva Ginecologica 2012 August;64(4):337-44

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: Italian

Hormone replacement therapy and urogenital disease in postmenopausal women

Della Martina M., Xodo S., Vogrig E., Rinuncini D., Ganzitti L., Driul L., Fabiani G., Marchesoni D.

Clinica di Ostetricia e Ginecologia, Azienda Ospedaliero Universitaria di Udine Udine, Italia


PDF


Estrogen deficit in postmenopausal women causes urogenital atrophy, which is responsible for a wide range of urinary disorders (urinary incontinence, urge incontinence, recurrent urinary infections) and genital disorders (prolapse, dispareunya, vaginal dryness). The efficacy of estrogen therapy on urinary incontinence is not yet demonstrated, but it is widely recognized that the topical use of estrogens lowers the risk of recurrent urinary infections and improves urogenital atrophy.

top of page